|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,169.00 KRW | -4.18% |
|
-3.79% | -34.40% |
| 06-21 | Amicogen, Inc. announced that it expects to receive KRW 9.9999989 billion in funding | CI |
| 05-14 | Amicogen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Company Valuation: Amicogen, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 730,075 | 620,699 | 379,320 | 412,059 | 211,591 | 98,951 |
| Change | - | -14.98% | -38.89% | 8.63% | -48.65% | -53.23% |
| Enterprise Value (EV) 1 | 729,365 | 662,875 | 491,053 | 523,099 | 323,107 | 185,858 |
| Change | - | -9.12% | -25.92% | 6.53% | -38.23% | -42.48% |
| P/E | 23.4x | 165x | -8.12x | -13x | -4.02x | -3.28x |
| PBR | 4.77x | 3.33x | 2.88x | 2.34x | 1.73x | 1.05x |
| PEG | - | -1.9x | 0x | 0.3x | -0.1x | 0.1x |
| Capitalization / Revenue | 6.3x | 4.97x | 2.63x | 2.58x | 1.22x | 2.36x |
| EV / Revenue | 6.3x | 5.31x | 3.4x | 3.27x | 1.86x | 4.43x |
| EV / EBITDA | 57.7x | 108x | 63.5x | 37.5x | 73.6x | -32.4x |
| EV / EBIT | 276x | -143x | -99.7x | 759x | -33.8x | -12.1x |
| EV / FCF | -197x | -41.8x | -10.5x | -6.75x | -4.86x | 6.03x |
| FCF Yield | -0.51% | -2.39% | -9.49% | -14.8% | -20.6% | 16.6% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 822 | 96 | -1,195 | -583.6 | -960.8 | -542.8 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 115,856 | 124,881 | 144,296 | 159,904 | 173,605 | 41,981 |
| EBITDA 1 | 12,644 | 6,143 | 7,739 | 13,953 | 4,391 | -5,744 |
| EBIT 1 | 2,645 | -4,627 | -4,926 | 689.4 | -9,563 | -15,375 |
| Net income 1 | 31,604 | 3,733 | -47,220 | -23,289 | -52,791 | -29,960 |
| Net Debt 1 | -710.4 | 42,176 | 111,733 | 111,040 | 111,516 | 86,907 |
| Reference price 2 | 19,200.00 | 15,875.00 | 9,700.00 | 7,560.00 | 3,860.00 | 1,782.00 |
| Nbr of stocks (in thousands) | 38,025 | 39,099 | 39,105 | 54,505 | 54,816 | 55,528 |
| Announcement Date | 3/17/21 | 3/22/22 | 3/21/23 | 3/20/24 | 3/19/25 | 3/23/26 |
1KRW in Million2KRW
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 55.39M | |
| 32.22x | 8.13x | 25.24x | 0.05% | 53.83B | |
| 19.5x | 6.01x | 13.15x | 1.63% | 52.1B | |
| -42.48x | 13.5x | -39.59x | -.--% | 23.48B | |
| -18.22x | 4.32x | -7.57x | -.--% | 23.13B | |
| 24.24x | 4.75x | 12.54x | -.--% | 19.36B | |
| 24.39x | 4.78x | 15.56x | -.--% | 17.56B | |
| 45.88x | 18.59x | 47.88x | 0.08% | 15.2B | |
| -505.73x | 35.47x | -1462.84x | -.--% | 14.83B | |
| 17.57x | 5.11x | 11.88x | -.--% | 14.06B | |
| Average | -44.74x | 11.19x | -153.75x | 0.2% | 23.36B | |
| Weighted average by Cap. | -18.52x | 9.52x | -82.82x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A092040 Stock
- Valuation Amicogen, Inc.
Select your edition
All financial news and data tailored to specific country editions
